JP2025521082A5 - - Google Patents
Info
- Publication number
- JP2025521082A5 JP2025521082A5 JP2024566227A JP2024566227A JP2025521082A5 JP 2025521082 A5 JP2025521082 A5 JP 2025521082A5 JP 2024566227 A JP2024566227 A JP 2024566227A JP 2024566227 A JP2024566227 A JP 2024566227A JP 2025521082 A5 JP2025521082 A5 JP 2025521082A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid residue
- protein
- seq
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22173131 | 2022-05-12 | ||
| EP22173131.8 | 2022-05-12 | ||
| PCT/EP2023/062652 WO2023217988A1 (en) | 2022-05-12 | 2023-05-11 | Stabilized pre-fusion hmpv fusion proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025521082A JP2025521082A (ja) | 2025-07-08 |
| JP2025521082A5 true JP2025521082A5 (cg-RX-API-DMAC7.html) | 2026-07-08 |
Family
ID=81653543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024566227A Pending JP2025521082A (ja) | 2022-05-12 | 2023-05-11 | 安定化融合前ｈｍｐｖ融合タンパク質 |
Country Status (16)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120548194A (zh) | 2023-01-18 | 2025-08-26 | 辉瑞公司 | 针对呼吸道疾病的疫苗 |
| WO2025126071A1 (en) | 2023-12-14 | 2025-06-19 | Pfizer Inc. | Rna molecules |
| WO2025144636A1 (en) * | 2023-12-26 | 2025-07-03 | The Scripps Research Institute | ENGINEERED hMPV F PROTEIN IMMUNOGENS AND RELATED VACCINES |
| WO2025163460A2 (en) * | 2024-01-30 | 2025-08-07 | Pfizer Inc. | Vaccines against respiratory diseases |
| WO2026018181A1 (en) | 2024-07-17 | 2026-01-22 | Pfizer Inc. | Immunogenic compositions and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| NZ230747A (en) | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US5786464C1 (en) | 1994-09-19 | 2012-04-24 | Gen Hospital Corp | Overexpression of mammalian and viral proteins |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| WO2003104467A1 (en) | 2002-04-25 | 2003-12-18 | Crucell Holland B.V. | Means and methods for the production of adenovirus vectors |
| SE0202110D0 (sv) | 2002-07-05 | 2002-07-05 | Isconova Ab | Iscom preparation and use thereof |
| SE0301998D0 (sv) | 2003-07-07 | 2003-07-07 | Isconova Ab | Quil A fraction with low toxicity and use thereof |
| ES2993107T3 (en) | 2016-10-17 | 2024-12-23 | Janssen Pharmaceuticals Inc | Recombinant virus replicon systems and uses thereof |
| JP7788787B2 (ja) | 2016-12-05 | 2025-12-19 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | 遺伝子発現増強のための組成物および方法 |
| CN118359709A (zh) * | 2019-05-21 | 2024-07-19 | 佐治亚大学研究基金会有限公司 | 结合人类偏肺病毒融合蛋白的抗体及其用途 |
| IL320367A (en) * | 2020-10-09 | 2025-06-01 | Univ Texas | Prefusion-stabilized hmpv f proteins |
-
2023
- 2023-05-11 AU AU2023269241A patent/AU2023269241A1/en active Pending
- 2023-05-11 GE GEAP202516650A patent/GEAP202516650A/en unknown
- 2023-05-11 WO PCT/EP2023/062652 patent/WO2023217988A1/en not_active Ceased
- 2023-05-11 KR KR1020247040979A patent/KR20250010642A/ko active Pending
- 2023-05-11 CN CN202380053513.6A patent/CN119562826A/zh active Pending
- 2023-05-11 CR CR20240493A patent/CR20240493A/es unknown
- 2023-05-11 PE PE2024002522A patent/PE20251395A1/es unknown
- 2023-05-11 IL IL316911A patent/IL316911A/en unknown
- 2023-05-11 CA CA3253332A patent/CA3253332A1/en active Pending
- 2023-05-11 EP EP23727473.3A patent/EP4522209A1/en active Pending
- 2023-05-11 JP JP2024566227A patent/JP2025521082A/ja active Pending
-
2024
- 2024-11-08 CL CL2024003418A patent/CL2024003418A1/es unknown
- 2024-11-11 JO JOJO/P/2024/0256A patent/JOP20240256A1/ar unknown
- 2024-11-11 MX MX2024013959A patent/MX2024013959A/es unknown
- 2024-11-11 DO DO2024000230A patent/DOP2024000230A/es unknown
- 2024-11-12 CO CONC2024/0015386A patent/CO2024015386A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11229694B2 (en) | Vaccine against RSV | |
| JP2018171063A5 (cg-RX-API-DMAC7.html) | ||
| US11759514B2 (en) | Stabilized pre-fusion RSV F proteins | |
| EP3998077B1 (en) | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo | |
| JP4925540B2 (ja) | ５−ヘリックスタンパク質 | |
| GB2598494A (en) | A subunit vaccine for treatment or prevention of a respiratory tract infection | |
| JP4006021B2 (ja) | ケモカインの生物学的活性の強化法 | |
| WO1997026359A1 (es) | Sistema de expresion de antigenos heterologos como proteinas de fusion | |
| JP2003529319A (ja) | ＨＩＶ−１ｇｐ４１を標的化する広範に中和する抗体を誘発する方法 | |
| CN101255197B (zh) | 血清白蛋白与白介素1受体拮抗剂的融合蛋白及应用 | |
| RU2018100181A (ru) | Модифицированный белок интерлейкина-7 и способы его применения | |
| CN103314010B (zh) | h[Gly2]GLP-2的固相合成 | |
| CA2187083A1 (fr) | Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation | |
| RU2003104524A (ru) | Masp-2, комплемент-связывающий фермент и его применение | |
| JP2023528207A5 (cg-RX-API-DMAC7.html) | ||
| CN116096736A (zh) | 新型冠状病毒rbd融合蛋白 | |
| WO2021247675A9 (en) | Coronavirus-binding agents and uses thereof | |
| RU2008146920A (ru) | Клещевой аллерген домашней пыли | |
| CN118725052A (zh) | 具有稳定融合前构象的呼吸道合胞病毒f蛋白 | |
| CN107226842A (zh) | 靶向pd-1的多肽及其应用 | |
| JPH08511542A (ja) | コイル状−コイルステムループ鋳型 | |
| CN119161495A (zh) | 呼吸道合胞病毒重构多肽及其应用 | |
| JP2025509352A5 (cg-RX-API-DMAC7.html) | ||
| WO1999062932A2 (en) | INHIBITION OF VIRAL INFECTION AND SPREAD WITH VIRAL AND RhoA-DERIVED PEPTIDES | |
| CN115197303B (zh) | 一种s蛋白的受体结合结构域的突变体及其应用 |